de Andrés, Clara <br/><br/>
Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis.  [electronic resource] 

 -  Journal of neuroimmunology  Jan 2007 
 - 204-11 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0165-5728 
<br/><br/><label>Standard No.: </label>10.1016/j.jneuroim.2006.09.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--therapeutic use<br/>Adult<br/>CD4-Positive T-Lymphocytes--metabolism<br/>Cohort Studies<br/>Female<br/>Glucocorticoid-Induced TNFR-Related Protein<br/>Humans<br/>In Vitro Techniques<br/>Interferon beta-1a<br/>Interferon-beta--therapeutic use<br/>Interleukin-2 Receptor alpha Subunit--metabolism<br/>Longitudinal Studies<br/>Male<br/>Middle Aged<br/>Multiple Sclerosis, Relapsing-Remitting--blood<br/>Receptors, Nerve Growth Factor--metabolism<br/>Receptors, Tumor Necrosis Factor--metabolism<br/>T-Lymphocyte Subsets--pathology<br/>T-Lymphocytes, Regulatory--immunology<br/>Treatment Outcome